BPC-157
What BPC-157 research actually shows
A synthetic peptide studied for tissue repair. What the animal evidence supports, and where the human data runs out.
Dr Baard · MBChB · 19 September 2026 · 1 min read
What it is
BPC-157 is a synthetic peptide derived from a sequence found in human gastric juice. It has been studied since the 1990s, almost entirely in animal models.
What the evidence shows
Rodent studies report associations between BPC-157 administration and faster closure of tendon and ligament injuries, alongside changes in growth factor expression. The mechanism most often proposed involves angiogenesis — the formation of new blood vessels at the site of injury.
Human data is the gap. There are no published randomised controlled trials of adequate size, and the peptide is not registered as a medicine in South Africa.
How to read this
An association observed in rodents is a reason to investigate, not a conclusion about people. Anyone considering this should discuss it with a clinician who knows their history.